Skip to main content
INSMED Inc logo

INSMED Inc — Investor Relations & Filings

Ticker · INSM ISIN · US4576693075 LEI · 529900Q55QAG41CCAC11 US Manufacturing
Open in API
Filings indexed 1,323 across all filing types
Latest filing 2011-03-28 Director's Dealing
Country US United States of America
Listing US INSM

About INSMED Inc

https://insmed.com/

Insmed Incorporated is a global biopharmaceutical company dedicated to developing and commercializing therapies for patients with serious and rare diseases. The company's primary focus is on addressing areas of high unmet medical need. Its marketed product, Arikayce (liposomal amikacin for inhalation), is a treatment for Mycobacterium avium complex (MAC) lung disease. Insmed leverages proprietary technologies, such as its advanced liposomal pulmonary delivery system, to create novel treatments. The company maintains a diverse pipeline of investigational medicines and is actively advancing potential new therapies through various stages of clinical trials.

Recent filings

Filing Released Lang Actions
4 Filing
Director's Dealing
2011-03-28 English
4 Filing
Director's Dealing
2011-03-28 English
4 Filing
Director's Dealing
2011-03-25 English
4 Filing
Director's Dealing
2011-03-24 English
8-K Filing
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content includes information about regaining compliance with NASDAQ listing standards and FDA clearance for a clinical trial, both announced via press releases attached as exhibits. There are no financial statements or detailed financial data presented. The document is primarily an event announcement rather than a financial report or detailed management discussion. It does not fit categories like Annual Report, Interim Report, Earnings Release, or Management Reports. It is also not a proxy, voting result, or governance document. Given the nature of the filing and the absence of substantive financial data, this is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous SEC filings like Form 8-K that do not fit other specific categories.
2011-03-21 English
10-K Filing
Annual Report FY 2010
2011-03-16 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.